Penumbra Inc
PENNYSECIK 1321732HealthcareFiscal year ends Dec 31
Reports and events: 154 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2916:45 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001321732-26-000043 |
| 2026-10-2916:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001321732-26-000042 |
| 2026-07-3016:44 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001321732-26-000037 |
| 2026-07-3016:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001321732-26-000036 |
| 2026-06-2216:19 ET | 8-K | 5.07 Shareholder vote results | 0001321732-26-000030 |
| 2026-05-0709:00 ET | 8-K | 5.07 Shareholder vote results | 0001321732-26-000024 |
| 2026-05-0616:45 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001321732-26-000019 |
| 2026-05-0616:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001321732-26-000018 |
| 2026-04-2916:18 ET | DEF 14A | Proxy statementPeriod 2026-06-18 | 0001321732-26-000010 |
| 2026-02-2513:27 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001321732-26-000007 |
| 2026-02-2513:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001321732-26-000006 |
| 2026-01-1507:15 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950103-26-000523 |
| 2025-11-0516:44 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001321732-25-000109 |
| 2025-11-0516:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001321732-25-000108 |
| 2025-08-2709:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001321732-25-000101 |
| 2025-07-2916:53 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001321732-25-000098 |
| 2025-07-2916:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001321732-25-000097 |
| 2025-05-3016:13 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001321732-25-000093 |
| 2025-04-2316:44 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001321732-25-000086 |
| 2025-04-2316:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001321732-25-000085 |
| 2025-04-1616:27 ET | DEF 14A | Proxy statementPeriod 2025-05-28 | 0001321732-25-000074 |
| 2025-02-2116:17 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001321732-25-000036 |
| 2025-02-1816:44 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001321732-25-000012 |
| 2025-02-1816:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001321732-25-000010 |
| 2024-10-3016:47 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001321732-24-000118 |
| 2024-10-3016:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001321732-24-000116 |
| 2024-08-1307:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001321732-24-000090 |
| 2024-07-3016:45 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001321732-24-000087 |
| 2024-07-3016:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001321732-24-000086 |
| 2024-06-0716:33 ET | 8-K | 5.07 Shareholder vote results | 0001321732-24-000075 |
| 2024-05-0716:44 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001321732-24-000060 |
| 2024-05-0716:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001321732-24-000058 |
| 2024-04-2416:21 ET | DEF 14A | Proxy statementPeriod 2024-06-05 | 0001321732-24-000052 |
| 2024-03-2116:08 ET | 8-K | 4.01 Change of auditor | 0001321732-24-000042 |
| 2024-02-2216:46 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001321732-24-000025 |
| 2024-02-2216:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001321732-24-000023 |
| 2023-11-0216:57 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001321732-23-000127 |
| 2023-11-0216:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001321732-23-000126 |
| 2023-08-0316:46 ET | 8-K/A | 5.07 Shareholder vote results | 0001321732-23-000091 |
| 2023-08-0116:44 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001321732-23-000088 |
| 2023-08-0116:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001321732-23-000086 |
| 2023-06-0217:03 ET | 8-K | 5.07 Shareholder vote results | 0001321732-23-000072 |
| 2023-05-0216:44 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001321732-23-000062 |
| 2023-05-0216:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001321732-23-000060 |
| 2023-04-1916:16 ET | DEF 14A | Proxy statement | 0001321732-23-000054 |
| 2023-02-2316:45 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001321732-23-000034 |
| 2023-02-2316:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001321732-23-000032 |
| 2022-11-0316:45 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001321732-22-000104 |
| 2022-11-0316:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001321732-22-000103 |
| 2022-08-0516:20 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001321732-22-000079 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 19:10 ET. Listed shows no prices and gives no investment advice.